Log in

NASDAQ:RDEA - Ardea Biosciences Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Ardea Biosciences, Inc (Ardea) is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of serious diseases. The Company's product portfolio includes Lesinurad (RDEA594), RDEA3170 and BAY 86-9766 (RDEA119). Lesinurad (RDEA594) is an inhibitor of the URAT1 kidney transporter for the treatment of gout. RDEA3170 is a URAT1 kidney transporter inhibitors for the treatment of gout. Read More…

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:RDEA
CUSIPN/A
Phone+1-858-6526500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive RDEA News and Ratings via Email

Sign-up to receive the latest news and ratings for RDEA and its competitors with MarketBeat's FREE daily newsletter.


Ardea Biosciences (NASDAQ:RDEA) Frequently Asked Questions

What is Ardea Biosciences' stock symbol?

Ardea Biosciences trades on the NASDAQ under the ticker symbol "RDEA."

Has Ardea Biosciences been receiving favorable news coverage?

News articles about RDEA stock have been trending very negative recently, InfoTrie Sentiment reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Ardea Biosciences earned a daily sentiment score of -3.6 on InfoTrie's scale. They also gave media stories about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Ardea Biosciences.

What is Ardea Biosciences' official website?

The official website for Ardea Biosciences is http://www.ardeabio.com/.

How can I contact Ardea Biosciences?

Ardea Biosciences' mailing address is 4939 Directors Pl, SAN DIEGO, CA 92121-3829, United States. The biotechnology company can be reached via phone at +1-858-6526500.


MarketBeat Community Rating for Ardea Biosciences (NASDAQ RDEA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  84 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  171
MarketBeat's community ratings are surveys of what our community members think about Ardea Biosciences and other stocks. Vote "Outperform" if you believe RDEA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RDEA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel